Table 2

Genes upregulated by AI treatment

ID
Symbol
Description
Unigene
Fold
LFDR

HSI022G08
LUM
Lumican
Hs.406475
2.87
0.11
HSI101E05
ODF2L
Outer dense fiber of sperm tails 2-like
Hs.149360
2.80
0.07
HSI027H04
IGJ
Immunoglobulin J polypeptide
Hs.381568
2.73
0.07
HSI082D05
RNH1
Ribonuclease/angiogenin inhibitor 1
Hs.530687
2.51
0.00
HSI056B04
COL3A1
Collagen, type III, alpha 1
Hs.443625
2.50
0.00
HSI182D05
MRC1L1
Mannose receptor, C type 1
Hs.461247
2.45
0.06
HSI067F08
C21orf70
Chromosome 21 open reading frame 70
Hs.410830
2.44
0.00
HSI127E04
CALD1
Caldesmon 1
Hs.490203
2.37
0.11
HSI030C06
PTPRC
Protein tyrosine phosphatase, receptor type, C
Hs.192039
2.36
0.11
HSI067H02
ASPN
Asporin (LRR class 1)
Hs.435655
2.34
0.00
HSI066B08
COL14A1
Collagen, type XIV, alpha 1 (undulin)
Hs.409662
2.28
0.11
HSI049B12
COL1A2
Collagen, type I, alpha 2
Hs.489142
2.28
0.00
HSI049G07
DCN
Decorin
Hs.156316
2.28
0.00
HSI067E05
MRC1L1
Mannose receptor, C type 1
Hs.461247
2.22
0.05
HSI101D05
IFT122
Intraflagellar transport 122 homolog (Chlamydomonas)
Hs.477537
2.17
0.03
HSI183E05
PDGFRA
Platelet-derived growth factor receptor, alpha
Hs.74615
2.14
0.09
HSI031A12
FSTL1
Follistatin-like 1
Hs.269512
2.12
0.00
HSI183H01
COL5A2
Collagen, type V, alpha 2
Hs.445827
2.11
0.00
HSI055A11
ECM2
Extracellular matrix protein 2
Hs.117060
2.08
0.09
HSI018G02
SPON1
Spondin 1, extracellular matrix protein
Hs.445818
2.06
0.00
HSI183B01
PDGFRA
Platelet-derived growth factor receptor, alpha
Hs.74615
2.04
0.01
HSI037C02
CPVL
Carboxypeptidase, vitellogenic-like
Hs.233389
2.03
0.06
HSI062B08
SAS10
Disrupter of silencing 10
Hs.322901
2.01
0.00
HSI129E10
ADAM12
ADAM metallopeptidase domain 12 (meltrin alpha)
Hs.386283
2.00
0.00
HSI183G08
RGS1
Regulator of G-protein signalling 1
Hs.75256
1.98
0.18
HSI054F01
VIM
Vimentin
Hs.533317
1.97
0.00
HSI048C08
CTGF
Connective tissue growth factor
Hs.410037
1.97
0.00
HSI183G05
SPARC
Secreted protein, acidic, cysteine-rich (osteonectin)
Hs.111779
1.96
0.00
HSI139G09
ADAMTS2
ADAM metallopeptidase with thrombospondin motif 2
Hs.23871
1.96
0.00
HSI018D05
FBLN1
Fibulin 1
Hs.24601
1.95
0.00
HSI040E08
DUSP1
Dual specificity phosphatase 1
Hs.171695
1.95
0.00
HSI082C05
MAN1A1
Mannosidase, alpha, class 1A, member 1
Hs.102788
1.94
0.01
HSI098G12
RARRES1
Retinoic acid receptor responder 1
Hs.131269
1.94
0.00
HSI044C09
SAT
Spermidine/spermine N1-acetyltransferase
Hs.28491
1.92
0.09
HSI030F05
HTRA1
HtrA serine peptidase 1
Hs.501280
1.92
0.00
HSI088D11
CILP
Cartilage intermediate layer protein
Hs.442180
1.91
0.00
HSI040E09
MME
Membrane metallo-endopeptidase (CALLA, CD10)
Hs.307734
1.91
0.00
HSI028G12
PDGFRA
Platelet-derived growth factor receptor, alpha
Hs.74615
1.89
0.00
HSI060C05
FN1
Fibronectin 1
Hs.203717
1.89
0.00
HSI045G12
CXCL12
Chemokine ligand 12 (stromal cell-derived factor 1)
Hs.522891
1.88
0.00

Shown are the first 40 upregulated genes from a paired SAM analysis, which identified 1,365 genes to be upregulated by aromatase inhibitor (AI) treatment below a local false discovery rate of 1% (LFDR). The genes are ranked according to their fold change.

Mackay et al. Breast Cancer Research 2007 9:R37   doi:10.1186/bcr1732